Cancer

Tattooless Radiation Therapy Benefits More Than Skin Deep

Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

Retrospective study yields clues to understanding risk of secondary myeloid neoplasms

Investigational PET Imaging Agent Being Explored as a Predictive Biomarker For Response to Standard Chemotherapies

Pilot Study at Cleveland Clinic is Testing Feasibility and Biodistribution

Distinct PHTS-related Breast Cancer Genomic Characteristics Discovered

Findings support need for personalized disease management

Tumors with Specific Genetic Mutations Show Response to Immune Checkpoint Blockade Therapy

Pathogenic POLE/POLD1 mutations lead to improved response to immune checkpoint blockade therapy

Radium Knocks Out Tumor Cells in Case of Unresectable Paraspinal Osteosarcoma

The decision to use 223-radium, and an outcome that exceeded expectations

Biosignatures Optimize Adjuvant Radiation Therapy Decisions in Patients with DCIS

Tumor genomics offer clues for identifying high risk of relapse